Prostaglandins and cancer.
D000595:Amino Acid Sequence; D000818:Animals; D000875:Anthralin / Q000494:pharmacology; D001665:Binding Sites / Q000187:drug effects; D002400:Cathartics / Q000494:pharmacology; D002471:Cell Transformation, Neoplastic / Q000139:chemically induced; D006801:Humans; D008958:Models, Molecular; D009369:Neoplasms / Q000139:chemically induced* / Q000188:drug therapy; D009374:Neoplasms, Experimental / Q000139:chemically induced; D010703:Phorbol Esters / Q000494:pharmacology; D011034:Podophyllotoxin / Q000494:pharmacology; D011073:Polyamines / Q000494:pharmacology; D011453:Prostaglandins / Q000494:pharmacology*; D011982:Receptors, Prostaglandin / Q000187:drug effects
D002400:Cathartics; D010703:Phorbol Esters; D011073:Polyamines; D011453:Prostaglandins; D011982:Receptors, Prostaglandin; D011034:Podophyllotoxin; D000875:Anthralin